Aardvark Therapeutics (AARD) Non Operating Income (2024 - 2026)
Aardvark Therapeutics (AARD) reported Non Operating Income of $876000.0 for Q1 2026, down 24.48% on a YoY basis from $1.2 million in Q1 2025, and down 20.8% sequentially from $1.1 million in Q4 2025.
Aardvark Therapeutics (AARD) Non Operating Income (2024 - 2026) Analysis & Trends
Aardvark Therapeutics (AARD) has 3 years of Non Operating Income data on file, last reported at $876000.0 in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income fell 24.48% year-over-year to $876000.0; the trailing twelve-month figure through Mar 2026 stood at $4.8 million (up 44.17% YoY), and the FY2025 full-year result was $5.1 million, up 133.68% from the prior year.
- Non Operating Income fell to $876000.0 in Q1 2026, from $1.1 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $1.5 million in Q2 2025 to a low of -$7000.0 in Q1 2024.
- A 3-year average of $911888.9 and a median of $909000.0 in 2024 frame the typical range for Non Operating Income.
- Across the five-year window, Non Operating Income surged 16671.43% in 2025 and retreated 24.48% in 2026, its largest moves.
- Tracing AARD's Non Operating Income over 3 years: stood at $671000.0 in 2024, then surged by 64.83% to $1.1 million in 2025, then retreated by 20.8% to $876000.0 in 2026.
- Business Quant data shows AARD's Non Operating Income at $876000.0 in Q1 2026, $1.1 million in Q4 2025, and $1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | Aardvark Therapeutics | 139.40 Mn | 19.44 Mn | - | 876,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 876,000.00 |
| Dec 31, 2025 | 1.11 Mn |
| Sep 30, 2025 | 1.39 Mn |
| Jun 30, 2025 | 1.48 Mn |
| Mar 31, 2025 | 1.16 Mn |
| Dec 31, 2024 | 671,000.00 |
| Sep 30, 2024 | 909,000.00 |
| Jun 30, 2024 | 624,000.00 |
| Mar 31, 2024 | -7,000.00 |